Clinical Trial

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Patients on this study will self administer Prednisone for three days before starting Radiation Therapy (RT) and continue to take 60 mg/day during the first three fractions of RT.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-06-02; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2024-02-01
Trial Details
NCT Number NCT05901519
Lead Sponsor University of Michigan Rogel Cancer Center
Conditions Hepatocellular Carcinoma
Enrollment 20 participants
Start Date 2024-02-16
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-13